OGN | Organon & Co.NYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$13.85
+$0.03 (+0.22%)

Organon & Co. (OGN) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.

The 50 SMA has sat above the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $13.85 vs 50 $13.74 / 200 $11.57
Projection
No cross projected
Test
No active test
Last cross
Golden cross 12 May 2026 ยท projected 18 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $13.84 vs 50 $10.89 / 200 $15.52
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
above both $13.85 vs 50 $13.76 / 200 $13.65
Projection
No cross projected
Test
No active test
Last cross
Golden cross 27 Apr 2026 ยท projected 30 bars out

Cross history

14
crosses on record since 2022
7 golden7 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
12 May 2026Golden steepdaily18 bars outNot tested
27 Apr 2026Golden4-hour30 bars outNot tested
3 Mar 2026Death4-hour25 bars outNot tested
4 Feb 2026Golden4-hour29 bars out4 bar cross test
28 Oct 2025Death4-hour26 bars outNot tested

About OGN

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$31.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.